Avoid common mistakes on your manuscript.
Correction to: Clinical and Experimental Nephrology https://doi.org/10.1007/s10157-021-02159-9
The article “Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study”, written by Shuichi Ito · Yuya Nishiyama · Kenkichi Sugiura and Kazuaki Enya was originally published Online First without Open Access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on 16th December 2021 to © The Author(s) 2021 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Ito, S., Nishiyama, Y., Sugiura, K. et al. Correction to: Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study. Clin Exp Nephrol 26, 359 (2022). https://doi.org/10.1007/s10157-021-02176-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-021-02176-8